56
Participants
Start Date
April 29, 2015
Primary Completion Date
August 5, 2020
Study Completion Date
August 5, 2020
afatinib
AKH - Medical University of Vienna, Vienna
St. Anna Children-Hospital, Children's Cancer Research, Wien, Vienna
Sydney Childrens Hospital, Randwick
Rigshospitalet, København, Børneonkologisk Afsnit 5002, København Ø
Charité - Universitätsmedizin Berlin, Berlin
Istituto G. Gaslini, Genova
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Hospital Infantil Universitario Niño Jesus, Madrid
HOP Toulouse, Pédiat, Toulouse, Toulouse
HOP Pellegrin, Bordeaux
Azienda Ospedaliera Universitaria di Padova, Padua
Universitätsklinikum Essen AöR, Essen
University of Wisconsin, Madison
CTR Oscar Lambret, Lille
CTR Leon Berard, Lyon
Universitätsklinikum Tübingen, Tübingen
INS Curie, Paris
The University of Texas Health Science Center at Houston, Houston
INS Gustave Roussy, Villejuif
Dana-Farber Cancer Institute, Boston
The Hospital for Sick Children, Toronto
Osp. Pediatrico Bambin Gesù, Roma
Erasmus MC - Sophia Kinderziekenhuis, Rotterdam
Hospital Vall d'Hebron, Barcelona
Birmingham Children's Hospital, Birmingham
Great Ormond Street Hospital, London
Royal Manchester Children's Hospital, Manchester
The Royal Marsden Hospital, Sutton
Lead Sponsor
Boehringer Ingelheim
INDUSTRY